Signaling Pathways - LPA Receptors - VEGFR - PARs - Myosin light chain kinases (MLCKs)
清除全部
-
C3342 MAZ51Target: VEGFRSummary: VEGFR3拮抗剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5864 Fruquintinib(HMPL-013)中文名: 呋喹替尼Target: VEGFRSummary: VEGFR1\2和3抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂 -
B6801 SCH 79797 dihydrochlorideTarget: PARsSummary: PAR1受体拮抗剂 -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B7515 1-Oleoyl lysophosphatidic acid sodium saltTarget: LPA ReceptorsSummary: 激活LPA受体 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂